1795 — Lotus Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- TWD82.38bn
- TWD92.20bn
- TWD16.96bn
- 79
- 27
- 98
- 83
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 977 | 1,304 | 1,870 | 3,940 | 5,103 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 563 | 714 | 806 | 485 | 194 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,713 | -779 | -3,316 | -1,643 | -4,893 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 420 | 1,949 | 120 | 3,719 | 1,614 |
Capital Expenditures | -1,106 | -1,998 | -1,616 | -3,069 | -3,275 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -1,283 | 873 | 38.9 | -1,587 | 25.7 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2,388 | -1,125 | -1,577 | -4,656 | -3,249 |
Financing Cash Flow Items | -1,146 | -2,429 | 558 | -558 | 0 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2,221 | -545 | 1,663 | 1,262 | 1,403 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 218 | 212 | 116 | 378 | -213 |